Currently, there are 162.02M common shares owned by the public and among those 116.99M shares have been available to trade.
The company’s stock has a 5-day price change of -16.65% and -20.20% over the past three months. It has a 12-month low price of $36.22 and touched a high of $147.39 over the same period. ALAB has an average intraday trading volume of 5.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -16.82%, -32.40%, and 1.66% respectively.
Institutional ownership of Astera Labs Inc (NASDAQ: ALAB) shares accounts for 59.52% of the company’s 162.02M shares outstanding.
It has a market capitalization of $12.61B. The earnings-per-share (ttm) stands at -$0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.49% over the week and 8.98% over the month.
Analysts forecast that Astera Labs Inc (ALAB) will achieve an EPS of 0.28 for the current quarter, 0.3 for the next quarter and 1.72 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.28 while analysts give the company a high EPS estimate of 0.28. Comparatively, EPS for the current quarter was 0.27 a year ago. Earnings per share for the fiscal year are expected to increase by 50.02%, and 36.10% over the next financial year.
Looking at the support for the ALAB, a number of firms have released research notes about the stock. Northland Capital stated their Outperform rating for the stock in a research note on January 28, 2025, with the firm’s price target at $120. Morgan Stanley coverage for the Astera Labs Inc (ALAB) stock in a research note released on January 21, 2025 offered a Equal-Weight rating with a price target of $142. Northland Capital was of a view on January 02, 2025 that the stock is Market Perform, while Citigroup gave the stock Buy rating on November 18, 2024, issuing a price target of $120. Morgan Stanley on their part issued Overweight rating on September 04, 2024.
